About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 941 entries already.
Entries by Max
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 abiraterone abiraterone acetate ADC ADT ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T CD3 clinical trial crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide EZH2 inhibitor HRR immunotherapy mcrpc mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- UPDATE: TALAPRO-2 Links Circulating Tumor DNA and Cancer Cell Clearance to Longer Progression-Free Survival November 20, 2026
- Phase 1/2 CROP Trial Reports 78% Five-Year Survival With SBRT and Intermittent ADT November 20, 2026
- UPDATE: Phase 1 Trial of Penetrium Shows Early PSA Declines and Metastatic Lesion Shrinkage in Resistant Prostate Cancer November 20, 2026
- Soon To Be Phase 1 Trial: EIK1006, a Next-Generation Androgen Receptor Antagonist November 19, 2026
